Skip to main content
. 2020 Feb 15;8(1):87. doi: 10.3390/vaccines8010087

Figure 1.

Figure 1

Characterization of nanovaccine. (A) Schematic illustration to show the step-by-step preparation of CNTs-M-VP7 nanovaccine. (B) Representative scanning electron microscopy image, and (C) transmission electron microscopy image of the SWCNTs-MG nanovaccine. (D) Raman analysis. (E) Dynamic light scattering analysis. (F) Zeta potential analysis. (G) Antigen release at 28 °C under two different pH conditions (pH 5.4 and 7.2) in vitro.